- Home
- RDHL vs BNZI Comparison
RDHL vs BNZI Comparison
Compare RDHL & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- BNZI
- Stock Information
- Founded
- RDHL 2009
- BNZI 2016
- Country
- RDHL Israel
- BNZI United States
- Employees
- RDHL N/A
- BNZI N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- BNZI
- Sector
- RDHL Health Care
- BNZI
- Exchange
- RDHL Nasdaq
- BNZI Nasdaq
- Market Cap
- RDHL 4.3M
- BNZI 11.5M
- IPO Year
- RDHL N/A
- BNZI N/A
- Fundamental
- Price
- RDHL $2.10
- BNZI $4.51
- Analyst Decision
- RDHL
- BNZI Strong Buy
- Analyst Count
- RDHL 0
- BNZI 1
- Target Price
- RDHL N/A
- BNZI $24.00
- AVG Volume (30 Days)
- RDHL 18.8K
- BNZI 4.2M
- Earning Date
- RDHL 08-28-2025
- BNZI 08-13-2025
- Dividend Yield
- RDHL N/A
- BNZI N/A
- EPS Growth
- RDHL N/A
- BNZI N/A
- EPS
- RDHL N/A
- BNZI N/A
- Revenue
- RDHL $8,042,999.00
- BNZI $6,827,490.00
- Revenue This Year
- RDHL $381.91
- BNZI $570.18
- Revenue Next Year
- RDHL N/A
- BNZI $34.44
- P/E Ratio
- RDHL N/A
- BNZI N/A
- Revenue Growth
- RDHL 23.17
- BNZI 52.95
- 52 Week Low
- RDHL $1.71
- BNZI $0.54
- 52 Week High
- RDHL $20.28
- BNZI $11.20
- Technical
- Relative Strength Index (RSI)
- RDHL 61.27
- BNZI 29.94
- Support Level
- RDHL $2.00
- BNZI $4.11
- Resistance Level
- RDHL $2.08
- BNZI $6.90
- Average True Range (ATR)
- RDHL 0.09
- BNZI 0.66
- MACD
- RDHL 0.03
- BNZI -0.03
- Stochastic Oscillator
- RDHL 100.00
- BNZI 23.09
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.